Browsing Tag
structural heart
3 posts
Resonetics closes Resolution Medical deal, targeting full-stack dominance in neuromodulation and structural heart
Resonetics completes acquisition of Resolution Medical, adding biosimulation and finished device assembly to its neuromodulation and structural heart platform. Read the full analysis.
Medtronic invests in Anteris (ASX: AVR) to fund DurAVR trial and TAVR platform expansion
Anteris Technologies has raised USD 320M, including USD 90M from Medtronic, to fund its global DurAVR heart valve trial. Read what this means for TAVR competition.
Anteris Technologies launches its pivotal trial phase for DurAVR THV, marking a regulatory turning point
Anteris Technologies launches the global PARADIGM pivotal trial of its DurAVR THV, challenging Edwards and Medtronic with biomimetic valve durability data—see how the race unfolds.